Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test

BACKGROUND: The excessive use of piperacillin/tazobactam (P/T) has promoted the emergence of P/T-resistant Enterobacterales. We reported that in Escherichia coli, P/T contributes to the development of extended-spectrum resistance to β-lactam/β-lactamase inhibitor (BL/BLI) (ESRI) in isolates that are...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez Villodres, Angel, Gálvez Benítez, Lydia, Arroyo, Manuel J., Méndez, Gema, Mancera, Luis, Vila Domínguez, Andrea, Lepe Jímenez, José Antonio, Smani, Younes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Antimicrobial Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423838/
https://www.ncbi.nlm.nih.gov/pubmed/35972021
http://dx.doi.org/10.1080/22221751.2022.2113746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423838/
https://www.ncbi.nlm.nih.gov/pubmed/35972021
http://dx.doi.org/10.1080/22221751.2022.2113746

Ejemplares similares